KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Fulgent Genetics (FLGT) Shares Repurchased (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Shares Repurchased for 7 consecutive years, with $2.2 million as the latest value for Q2 2025.

  • Quarterly Shares Repurchased changed N/A to $2.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Dec 2025, up 4737.33% year-over-year, with the annual reading at $10.9 million for FY2025, 4737.33% up from the prior year.
  • Shares Repurchased hit $2.2 million in Q2 2025 for Fulgent Genetics, down from $8.7 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $34.7 million in Q3 2022 to a low of $225000.0 in Q1 2024.
  • Historically, Shares Repurchased has averaged $14.0 million across 5 years, with a median of $8.7 million in 2025.
  • Biggest five-year swings in Shares Repurchased: decreased 21.32% in 2023 and later skyrocketed 3757.33% in 2025.
  • Year by year, Shares Repurchased stood at $513000.0 in 2021, then skyrocketed by 5564.33% to $29.1 million in 2022, then fell by 21.32% to $22.9 million in 2023, then plummeted by 99.02% to $225000.0 in 2024, then skyrocketed by 880.0% to $2.2 million in 2025.
  • Business Quant data shows Shares Repurchased for FLGT at $2.2 million in Q2 2025, $8.7 million in Q1 2025, and $225000.0 in Q1 2024.